• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性与新发卒中:一项系统评价和荟萃分析。

Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis.

作者信息

Fernandez Antonio B, Panza Gregory A, Cramer Benjamin, Chatterjee Saurav, Jayaraman Ramya, Wu Wen-Chih

机构信息

Division of Cardiology, Hartford Hospital, Hartford, Connecticut, United States of America.

University of Connecticut, School of Medicine, Farmington, CT, United States of America.

出版信息

PLoS One. 2015 Nov 18;10(11):e0142968. doi: 10.1371/journal.pone.0142968. eCollection 2015.

DOI:10.1371/journal.pone.0142968
PMID:26580396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4651536/
Abstract

BACKGROUND

Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness in people over 65 years old in the United States and has been associated with cardiovascular risk and decreased survival. There is conflicting data, however, regarding the contribution of AMD to the prediction of stroke.

AIM

To determine whether AMD is a risk indicator for incident stroke in a meta-analysis of available prospective and retrospective cohort studies published in the English literature.

METHODS

We performed a systematic literature search of all studies published in English with Pub Med and other databases from 1966 to August 2014, reporting stroke incidence in patients with macular degeneration. Two investigators independently extracted the data. A random effects model was used to report Odds ratios (OR), with corresponding 95% confidence intervals (CI). Meta-regression using a mixed linear model was used to understand potential heterogeneity amongst studies.

RESULTS

We identified 9 studies that reported stroke incidence in patients with and without early AMD (N = 1,420,978). No significant association was found between early AMD with incident stroke. Combined, these 9 studies demonstrated random effects (OR, 1.12; CI, 0.86-1.47; I2 = 96%). Meta-regression on baseline covariates of age, sex, and year of publication did not significantly relate to heterogeneity.

CONCLUSIONS

We found no significant relationship between AMD and incident stroke. Further studies are needed to clarify other causes of decreased survival in patients with AMD.

摘要

背景

年龄相关性黄斑变性(AMD)是美国65岁以上人群视力丧失和失明的主要原因,并且与心血管风险及生存率降低有关。然而,关于AMD对中风预测的贡献,数据存在冲突。

目的

在对英文文献中发表的现有前瞻性和回顾性队列研究进行的荟萃分析中,确定AMD是否为新发中风的风险指标。

方法

我们对1966年至2014年8月期间在PubMed和其他数据库中发表的所有英文研究进行了系统的文献检索,报告黄斑变性患者的中风发病率。两名研究人员独立提取数据。使用随机效应模型报告比值比(OR)及相应的95%置信区间(CI)。使用混合线性模型进行荟萃回归以了解各研究之间潜在的异质性。

结果

我们确定了9项报告有或无早期AMD患者中风发病率的研究(N = 1,420,978)。未发现早期AMD与新发中风之间存在显著关联。这9项研究综合显示随机效应(OR,1.12;CI,0.86 - 1.47;I² = 96%)。对年龄、性别和发表年份等基线协变量进行的荟萃回归与异质性无显著相关性。

结论

我们发现AMD与新发中风之间无显著关系。需要进一步研究以阐明AMD患者生存率降低的其他原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/b6c34a68fff7/pone.0142968.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/78ebafd21e34/pone.0142968.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/8cac8195b637/pone.0142968.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/b6c34a68fff7/pone.0142968.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/78ebafd21e34/pone.0142968.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/8cac8195b637/pone.0142968.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3db6/4651536/b6c34a68fff7/pone.0142968.g003.jpg

相似文献

1
Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis.年龄相关性黄斑变性与新发卒中:一项系统评价和荟萃分析。
PLoS One. 2015 Nov 18;10(11):e0142968. doi: 10.1371/journal.pone.0142968. eCollection 2015.
2
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
3
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.抗血管内皮生长因子生物类似药治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD015804. doi: 10.1002/14651858.CD015804.pub2.
4
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
5
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
6
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
7
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂可减缓与年龄相关的黄斑变性的进展。
Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5.
8
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD006927. doi: 10.1002/14651858.CD006927.pub5.
9
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
The role of dual antiplatelets in geographic atrophy secondary to non-neovascular aged-related macular degeneration.双重抗血小板治疗在非新生血管性年龄相关性黄斑变性继发地理性萎缩中的作用
Front Ophthalmol (Lausanne). 2022 Sep 8;2:984903. doi: 10.3389/fopht.2022.984903. eCollection 2022.
2
Internal Carotid Artery Stenosis and Ipsilateral Subretinal Drusenoid Deposits.颈内动脉狭窄与同侧视网膜下类脂沉积
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):37. doi: 10.1167/iovs.65.2.37.
3
Age-Related Macular Degeneration With Visual Disability Is Associated With Cardiovascular Disease Risk in the Korean Nationwide Cohort.

本文引用的文献

1
Reticular macular lesions: a review of the phenotypic hallmarks and their clinical significance.网状黄斑病变:表型特征及其临床意义综述
Clin Exp Ophthalmol. 2014 Dec;42(9):865-74. doi: 10.1111/ceo.12353. Epub 2014 Aug 7.
2
Is reticular macular disease a choriocapillaris perfusion problem?网状黄斑疾病是脉络膜毛细血管灌注问题吗?
Med Hypothesis Discov Innov Ophthalmol. 2012 Summer;1(2):37-41.
3
Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration.网状型黄斑病变与老年黄斑变性中的多灶性地图状萎缩有关。
与伴有视力障碍的年龄相关性黄斑变性相关的心血管疾病风险在韩国全国队列中。
J Am Heart Assoc. 2023 May 2;12(9):e028027. doi: 10.1161/JAHA.122.028027. Epub 2023 Apr 29.
4
, Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration.基因变异与CCL2、CCR2血清水平与年龄相关性黄斑变性的关联
Life (Basel). 2022 Jul 12;12(7):1038. doi: 10.3390/life12071038.
5
Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.眼病与死亡率、认知、疾病和可改变的风险因素:观察性研究荟萃分析的伞式评价。
Eye (Lond). 2022 Feb;36(2):369-378. doi: 10.1038/s41433-021-01684-x. Epub 2021 Jul 16.
6
The Relationship between Age-Related Macular Degeneration and Cardiovascular Disease: A Meta-Analysis.年龄相关性黄斑变性与心血管疾病的关系:一项荟萃分析。
Iran J Public Health. 2021 Feb;50(2):219-231. doi: 10.18502/ijph.v50i2.5334.
7
Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis.年龄相关性黄斑变性与冠状动脉钙进展:动脉粥样硬化的多民族研究。
PLoS One. 2018 Jul 18;13(7):e0201000. doi: 10.1371/journal.pone.0201000. eCollection 2018.
8
Insensitivity of PI3K/Akt/GSK3 signaling in peripheral blood mononuclear cells of age-related macular degeneration patients.年龄相关性黄斑变性患者外周血单个核细胞中PI3K/Akt/GSK3信号通路的不敏感性
J Biomed Res. 2017 Jan 19;31(3):248-255. doi: 10.7555/JBR.31.20160096.
9
Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.引入抗血管内皮生长因子疗法治疗年龄相关性黄斑变性并未增加心肌梗死、中风和死亡风险。
Ophthalmology. 2016 Oct;123(10):2225-31. doi: 10.1016/j.ophtha.2016.06.053. Epub 2016 Aug 11.
Retina. 2013 Oct;33(9):1850-62. doi: 10.1097/IAE.0b013e31828991b2.
4
Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.非新生血管性年龄相关性黄斑变性的视网膜下类脂沉积:形态、患病率、分布和发生模型。
Retina. 2013 Feb;33(2):265-76. doi: 10.1097/IAE.0b013e31827e25e0.
5
Age-related macular degeneration and long-term risk of stroke subtypes.年龄相关性黄斑变性与卒中亚型的长期风险。
Stroke. 2012 Jun;43(6):1681-3. doi: 10.1161/STROKEAHA.112.654632. Epub 2012 Apr 24.
6
Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.年龄相关性黄斑变性与心血管疾病事件:动脉粥样硬化的多种族研究。
Ophthalmology. 2012 Apr;119(4):765-70. doi: 10.1016/j.ophtha.2011.09.044. Epub 2011 Dec 23.
7
Age-related macular degeneration and the risk of stroke: the Rotterdam study.年龄相关性黄斑变性与中风风险:鹿特丹研究。
Stroke. 2011 Aug;42(8):2138-42. doi: 10.1161/STROKEAHA.111.616359. Epub 2011 Jun 16.
8
A prospective study of reticular macular disease.网状性黄斑病变的前瞻性研究。
Ophthalmology. 2011 Aug;118(8):1619-25. doi: 10.1016/j.ophtha.2011.01.029. Epub 2011 May 6.
9
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.与年龄相关性黄斑变性治疗相关的死亡、心肌梗死、出血和中风风险。
Arch Ophthalmol. 2010 Oct;128(10):1273-9. doi: 10.1001/archophthalmol.2010.223.
10
Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.年龄相关性黄斑变性中视网膜下类 drusen 样沉积物(网状假性 drusen)的患病率和意义。
Ophthalmology. 2010 Sep;117(9):1775-81. doi: 10.1016/j.ophtha.2010.01.027. Epub 2010 May 15.